Literature DB >> 24788973

Varying correlation between 18F-fluorodeoxyglucose positron emission tomography and dynamic contrast-enhanced MRI in carotid atherosclerosis: implications for plaque inflammation.

Juan Wang1, Hongbin Liu2, Jie Sun1, Hao Xue1, Leixing Xie1, Shengyuan Yu1, Changzai Liang1, Xu Han1, Zhiwei Guan1, Liqun Wei1, Chun Yuan1, Xihai Zhao1, Huijun Chen1.   

Abstract

BACKGROUND AND
PURPOSE: (18)F-fluorodeoxyglucose positron emission tomography and dynamic contrast-enhanced MRI have been proposed to quantitatively assess plaque inflammation by probing macrophages and neovessels, respectively. We examined their correlation to study the in vivo relationship between macrophage and neovessel activities in atherogenesis.
METHODS: Forty-one patients (34 men; aged 65±12 years) with a total of 68 carotid plaques (thickness ≥2 mm on ultrasound; 20 symptomatic) were assessed by both (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and dynamic contrast-enhanced MRI within 2 weeks, measured as target-to-background ratio and transfer constant (K(trans)), respectively.
RESULTS: Overall, the correlation between target-to-background ratio and K(trans) was weak and marginal (r=0.22; P=0.068). They were correlated in the symptomatic plaques (r=0.59; P=0.006) but not in the asymptomatic plaques (r=0.07; P=0.625; P=0.033 for difference in r). Neither target-to-background ratio nor K(trans) was significantly higher in the symptomatic plaques, but both showed an inverse relationship with time since last neurological event (r=-0.94 and -0.69 for target-to-background ratio and K(trans), respectively).
CONCLUSIONS: The correlation between (18)F-fluorodeoxyglucose positron emission tomography and dynamic contrast-enhanced MRI measurements varied with clinical conditions, pointing to a complex interplay between macrophages and neovessels under different pathophysiological conditions. The moderate correlation shown only in symptomatic plaques indicates the presence of acute plaque inflammation with increased metabolic activity and cytokine production by inflammatory cells.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  atherosclerosis; carotid arteries; magnetic resonance imaging; positron emission tomography

Mesh:

Substances:

Year:  2014        PMID: 24788973     DOI: 10.1161/STROKEAHA.114.005147

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

1.  Feasibility of carotid artery PET/MRI in psoriasis patients.

Authors:  Prabhakar Rajiah; Mojgan Hojjati; Ziang Lu; Vijaya Kosaraju; Sasan Partovi; James K O'Donnell; Christopher Longenecker; Grace A McComsey; Jackelyn B Golden; Fuad Muakkassa; Scott Santilli; Thomas S McCormick; Kevin D Cooper; Neil J Korman
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-08-20

Review 2.  Imaging inflammation and neovascularization in atherosclerosis: clinical and translational molecular and structural imaging targets.

Authors:  Eric A Osborn; Farouc A Jaffer
Journal:  Curr Opin Cardiol       Date:  2015-11       Impact factor: 2.161

Review 3.  Methods and challenges in quantitative imaging biomarker development.

Authors:  Richard G Abramson; Kirsteen R Burton; John-Paul J Yu; Ernest M Scalzetti; Thomas E Yankeelov; Andrew B Rosenkrantz; Mishal Mendiratta-Lala; Brian J Bartholmai; Dhakshinamoorthy Ganeshan; Leon Lenchik; Rathan M Subramaniam
Journal:  Acad Radiol       Date:  2015-01       Impact factor: 3.173

Review 4.  Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imaging.

Authors:  Rasmus Sejersten Ripa; Andreas Kjær
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

Review 5.  Dynamic Contrast-Enhanced MRI to Study Atherosclerotic Plaque Microvasculature.

Authors:  Raf H M van Hoof; Sylvia Heeneman; Joachim E Wildberger; M Eline Kooi
Journal:  Curr Atheroscler Rep       Date:  2016-06       Impact factor: 5.113

6.  Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits.

Authors:  Raf H M van Hoof; Evelien Hermeling; Judith C Sluimer; Julie Salzmann; Arnold P G Hoeks; Jérôme Roussel; Mat J A P Daemen; Harry Struijker-Boudier; Joachim E Wildberger; Sylvia Heeneman; M Eline Kooi
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

7.  Symptomatic Carotid Plaques Demonstrate Less Leaky Plaque Microvasculature Compared With the Contralateral Side: A Dynamic Contrast-Enhanced Magnetic Resonance Imaging Study.

Authors:  Geneviève A J C Crombag; Raf H M van Hoof; Robert J Holtackers; Floris H B M Schreuder; Martine T B Truijman; Tobien A H C M L Schreuder; Narender P van Orshoven; Werner H Mess; Paul A M Hofman; Robert J van Oostenbrugge; Joachim E Wildberger; M Eline Kooi
Journal:  J Am Heart Assoc       Date:  2019-04-16       Impact factor: 5.501

8.  Microvasculature and intraplaque hemorrhage in atherosclerotic carotid lesions: a cardiovascular magnetic resonance imaging study.

Authors:  Geneviève A J C Crombag; Floris H B M Schreuder; Raf H M van Hoof; Martine T B Truijman; Nicky J A Wijnen; Stefan A Vöö; Patty J Nelemans; Sylvia Heeneman; Paul J Nederkoorn; Jan-Willem H Daemen; Mat J A P Daemen; Werner H Mess; J E Wildberger; Robert J van Oostenbrugge; M Eline Kooi
Journal:  J Cardiovasc Magn Reson       Date:  2019-03-04       Impact factor: 5.364

Review 9.  Integrated cardiovascular assessment of atherosclerosis using PET/MRI.

Authors:  Nicholas R Evans; Jason M Tarkin; Elizabeth Pv Le; Rouchelle S Sriranjan; Andrej Corovic; Elizabeth A Warburton; James Hf Rudd
Journal:  Br J Radiol       Date:  2020-04-03       Impact factor: 3.039

10.  Scan-rescan reproducibility of quantitative assessment of inflammatory carotid atherosclerotic plaque using dynamic contrast-enhanced 3T CMR in a multi-center study.

Authors:  Huijun Chen; Jie Sun; William S Kerwin; Niranjan Balu; Moni B Neradilek; Daniel S Hippe; Daniel Isquith; Yunjing Xue; Kiyofumi Yamada; Suzanne Peck; Chun Yuan; Kevin D O'Brien; Xue-Qiao Zhao
Journal:  J Cardiovasc Magn Reson       Date:  2014-08-01       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.